Growth hormone - Hormone replacement for the somatopause?

Hormone Research

Volumn 53, Issue SUPPL. 3, 2000, Pages 37-41

  Savine, Richard ^a   Sönksen, Peter ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Ageing; Body composition; Growth hormone; Quality of life; Somatopause

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; IBUTAMOREN; PLACEBO; RECOMBINANT GROWTH HORMONE; SALCATONIN; SOMATOMEDIN C;

ADULT; AGED; AGING; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; MUSCLE STRENGTH; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 17544404567     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023531     Document Type: Conference Paper

References (40)

1. Toogood AA, O'Neill PA, Shalet SM: Beyond the somatopause: Growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 1996;82:460-465.
2. Saloman F, Cuneo RC, Hesp R, Sönksen PH: The effects of treatment with recombinant growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-1803.
3. Cuneo RC, Saloman F, Wiles CM, Sönksen PH: Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 1990;33(suppl 4):55-60.
4. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson B-Å: Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997;137:240-245.
5. Christ E, Cummings M, Russell-Jones D: Dyslipidaemia in adult growth hormone deficiency and the effect of GH replacement: A review. Trends Endocrinol Metab 1998;9(5):200-206.
6. Erfurth EM, Bülow B, Ekilsson J, Hagmar L: High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: Preliminary results. Growth Horm IGF Res 1999;9:21-24.
7. Cuneo RC, Saloman F, Wiles CM, Hesp R, Sönksen PH: Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. J Appl Physiol 1991;70: 695-700.
8. Russell-Jones DL, Watts GF, Weissberger A, Naoumova A, Myers J, Thompson GR, Sönksen PH: The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol 1994;41:345-350.
9. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J: Effect of long term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 1998;48:561-568.
10. Zadik Z, Calew SA, McCarter RJ, Meistas M, Kowarski AA: The influence of age on the 24-hour integrated growth hormone concentration in normal individuals. J Clin Endocrinol Metab 1985;60:137-140.
11. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundbwrg PA, Bengtsson B-Å: Serum insulin-like growth factor I in a random population of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1996;41:2209-2215.
12. Rudman D, Feller AG, Nagraj HS, Gergans CA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE: Effects of human growth hormone on men over 60 years old. N Engl J Med 1990;323:1-6.
13. Young A: Muscle function in old age. New Iss Neurosci 1998;1:141-156, 235-266.
14. Skelton DA, Grieg CA, Davies JM, Young A: Strength, power and related functional ability of healthy people aged 60-89 years. Age Ageing 1994;23:371-377.
15. Bohannon RW: Comfortable and maximum walking speed of adults aged 20-79 years: Reference values and determinants. Age Ageing 1997;26:15-19.
16. O'Connor: PhD thesis, Dublin, 1998.
17. Vahl N, Jørgensen JO, Jurik AG, Christiansen JS: Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated growth hormone secretion in healthy adults. J Clin Endocrinol Metab 1997;816:2209-2215.
18. Fall C, Hindmarsh P, Dennison E, Kellingray S, Barker D, Cooper C: Programming of growth hormone secretion and bone density in elderly men: A hypothesis. J Clin Endocrinol Metab 1998;83:135-139.
19. Sturgess I, Martin FC: Correlation of techniques of body composition, estimation of muscle strength and insulin-like growth factor I in fit elderly subjects. 15th World Congress of Gerontology, 1993.
20. Papdakis MA, Grady D, Tierney M: Insulin-like growth factor I and functional status in elderly men. J Am Geriatr Soc 1994;42:1350-1355.
21. Hartman ML, Clasey CL, Weltman JY, Wilderman L, Kannaley JA, Freund SB, Teates CD, Bouchard C, Thornton MO, Weltman A: Fitness is related to 24-hour GH release in men but not women. Endocrinol Metab 1997; 4(suppl A):90.
22. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW, Draper MW: Effects of human growth hormone on body composition in elderly men. Horm Res 1991;36(suppl 1):73-81.
23. Karlsson C, Stenlof K, Gudmundar Johansson PM, Björntorp P, Bengtsson B-Å, Carlsson B, Carlsson L, Sjöström L: Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men. Eur J Endocrinol 1998;138:408-414.
24. Welle S, Thornton C, Stott M, McHenry B: Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 1996;83: 3239-3244.
25. Papdakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C: Growth hormone replacement in healthy older men improves body composition, but not functional ability. Ann Intern Med 1996;124:708-716.
26. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R: Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly men. J Clin Endocrinol Metab 1994;79:470-479.
27. Holloway L, Kohleier L, Kent K, Marcus R: Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab 1997;82:1111-1117.
28. Yarasheski KE, Campbell JA, Kohrt WM: Effect of resistance exercise and growth hormone on bone density in older men. Clin Endocrinol 1997;47:223-229.
29. Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA, Sönksen PH: Recombinant human growth hormone (GH) treatment in elderly patients undergoing total hip replacement: Effects on muscle mass and strength. Endocrinol Metab 1997;4(suppl A):18.
30. Ahlmen J, Johnsson G, Johansson A, Bengtsson B-Å: Beneficial effects of growth hormone treatment in elderly patients on dialysis. Endocrinol Metab 1997;4(suppl A):18.
31. Veldhuis JD, Iranmanesh A: Physiological regulation of the human growth hormone (GH) insulin-like growth factor type I (IGF-I) axis: Predominant impact of age, obesity, gonadal function and sleep. Sleep 1996;19(suppl 10): S221-S224.
32. Guldner J, Scheir T, Friess E, Colla M, Holsboer F, Steiger A: Reduced efficacy of growth hormone releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging 1997;18:491-495.
33. Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellatoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG: Effects of single nightly injections of growth hormone releasing hormone (GHRH 1-29) in healthy elderly men. Metab Clin Exp 1997;46:89-96.
34. Corpas E, Harman SM, Pineyro MA, Robertson R, Blackman MR: Growth hormone (GH)-releasing hormone (1-29) twice daily reverses the decreased GH and insulin-like growth factor I levels in old men. J Clin Endocrinol Metab 1992;75:530-535.
35. Corpas E, Harman SM, Pineyro MA, Robertson R, Blackman MR: Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor I levels in old men. J Clin Endocrinol Metab 1993;76:134-138.
36. Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO: Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 1996;81:4249-4257.
37. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA: Testosterone administration increases IGF-I in normal men. J Clin Endocrinol Metab 1993;77: 776-779.
38. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA: GH deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997;82: 550-555.
39. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO: Both oral and transdermal oestrogen increase growth hormone release in post-menopausal women: A clinical research center study. J Clin Endocrinol Metab 1996;81: 2250-2256.
40. Bellatoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR: Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A clinical research center study. J Clin Endocrinol Metab 1996;81:2848-2853.